JP2014533357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014533357A5 JP2014533357A5 JP2014540007A JP2014540007A JP2014533357A5 JP 2014533357 A5 JP2014533357 A5 JP 2014533357A5 JP 2014540007 A JP2014540007 A JP 2014540007A JP 2014540007 A JP2014540007 A JP 2014540007A JP 2014533357 A5 JP2014533357 A5 JP 2014533357A5
- Authority
- JP
- Japan
- Prior art keywords
- synuclein
- level
- subject
- antibody
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003802 alpha-Synuclein Human genes 0.000 claims description 128
- 108090000185 alpha-Synuclein Proteins 0.000 claims description 128
- 102000004965 antibodies Human genes 0.000 claims description 82
- 108090001123 antibodies Proteins 0.000 claims description 82
- 210000004556 Brain Anatomy 0.000 claims description 50
- 239000000427 antigen Substances 0.000 claims description 50
- 102000038129 antigens Human genes 0.000 claims description 50
- 108091007172 antigens Proteins 0.000 claims description 50
- 210000002381 Plasma Anatomy 0.000 claims description 30
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 24
- 201000010099 disease Diseases 0.000 claims description 19
- 102000019355 Synucleins Human genes 0.000 claims description 15
- 108050006783 Synucleins Proteins 0.000 claims description 15
- 230000002093 peripheral Effects 0.000 claims description 14
- 230000035695 Efflux Effects 0.000 claims description 10
- 206010061536 Parkinson's disease Diseases 0.000 claims description 9
- 210000004369 Blood Anatomy 0.000 claims description 6
- 208000008404 Lewy Body Variant of Alzheimer Disease Diseases 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 208000001089 Multiple System Atrophy Diseases 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 206010001897 Alzheimer's disease Diseases 0.000 claims description 3
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 claims description 3
- 206010070976 Craniocerebral injury Diseases 0.000 claims description 3
- 206010012289 Dementia Diseases 0.000 claims description 3
- 201000010374 Down syndrome Diseases 0.000 claims description 3
- 208000009829 Lewy Body Disease Diseases 0.000 claims description 3
- 201000002832 Lewy body dementia Diseases 0.000 claims description 3
- 208000001094 Neuroaxonal Dystrophy Diseases 0.000 claims description 3
- HVAUUPRFYPCOCA-AREMUKBSSA-O PAF Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP(O)(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-O 0.000 claims description 3
- 208000000609 Pick Disease of the Brain Diseases 0.000 claims description 3
- 201000011585 Pick's disease Diseases 0.000 claims description 3
- 208000005765 Traumatic Brain Injury Diseases 0.000 claims description 3
- 206010044688 Trisomy 21 Diseases 0.000 claims description 3
- 201000011240 frontotemporal dementia Diseases 0.000 claims description 3
- 230000000366 juvenile Effects 0.000 claims description 3
- 201000006443 neuroaxonal dystrophy Diseases 0.000 claims description 3
- 206010028289 Muscle atrophy Diseases 0.000 claims description 2
- 102000005632 Single-Chain Antibodies Human genes 0.000 claims description 2
- 108010070144 Single-Chain Antibodies Proteins 0.000 claims description 2
- 238000010253 intravenous injection Methods 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 201000010901 lateral sclerosis Diseases 0.000 claims description 2
- 230000020763 muscle atrophy Effects 0.000 claims description 2
- 201000000585 muscular atrophy Diseases 0.000 claims description 2
- 230000004770 neurodegeneration Effects 0.000 claims description 2
- 230000001568 sexual Effects 0.000 claims description 2
- 208000002593 Pantothenate Kinase-Associated Neurodegeneration Diseases 0.000 description 3
- 206010002026 Amyotrophic lateral sclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 230000002596 correlated Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161554924P | 2011-11-02 | 2011-11-02 | |
| US61/554,924 | 2011-11-02 | ||
| PCT/US2012/062430 WO2013066818A1 (en) | 2011-11-02 | 2012-10-29 | USE OF AN ANTI-α-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF α-SYNUCLEIN IN THE BRAIN |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014533357A JP2014533357A (ja) | 2014-12-11 |
| JP2014533357A5 true JP2014533357A5 (xx) | 2015-10-15 |
| JP6263473B2 JP6263473B2 (ja) | 2018-01-31 |
Family
ID=48192661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540007A Active JP6263473B2 (ja) | 2011-11-02 | 2012-10-29 | 脳における高レベルのα−シヌクレインを診断するための抗α−シヌクレイン抗体の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20140295465A1 (xx) |
| EP (1) | EP2773957B1 (xx) |
| JP (1) | JP6263473B2 (xx) |
| KR (1) | KR102036938B1 (xx) |
| CN (2) | CN107091931A (xx) |
| AU (1) | AU2012332814B2 (xx) |
| BR (1) | BR112014010664A2 (xx) |
| CA (1) | CA2854131C (xx) |
| EA (1) | EA034213B1 (xx) |
| HK (1) | HK1201585A1 (xx) |
| IL (1) | IL232373B (xx) |
| MX (1) | MX356797B (xx) |
| WO (1) | WO2013066818A1 (xx) |
| ZA (1) | ZA201403879B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5810413B2 (ja) | 2008-12-19 | 2015-11-11 | バイオジェン インターナショナル ニューロサイエンス ゲーエムベーハー | ヒト抗アルファシヌクレイン自己抗体 |
| WO2012177972A1 (en) | 2011-06-23 | 2012-12-27 | Biogen Idec International Neuroscience Gmbh | Anti-alpha synuclein binding molecules |
| EP3207057A2 (en) | 2014-10-16 | 2017-08-23 | F. Hoffmann-La Roche AG | Anti-alpha-synuclein antibodies and methods of use |
| JP6273338B1 (ja) * | 2016-12-05 | 2018-01-31 | 磁量生技股▲ふん▼有限公司 | パーキンソン病からパーキンソン病認知症を特定する方法 |
| JP6908709B2 (ja) * | 2017-01-06 | 2021-07-28 | エービーエル バイオ インコーポレイテッド | 抗α−ｓｙｎ抗体およびその使用 |
| AU2018206279B2 (en) * | 2017-01-06 | 2020-09-03 | Abl Bio Inc. | Anti-alpha-syn antibody and use thereof |
| JP7136790B2 (ja) | 2017-02-17 | 2022-09-13 | ブリストル－マイヤーズ スクイブ カンパニー | アルファ－シヌクレインに対する抗体およびその使用 |
| GB201803553D0 (en) | 2018-03-06 | 2018-04-18 | Univ Newcastle | Detection of pathological protein aggregation |
| WO2020009482A1 (ko) * | 2018-07-03 | 2020-01-09 | 에이비엘바이오 주식회사 | 항 알파-시누클레인 항체 및 그 용도 |
| EP3629021A1 (en) * | 2018-09-26 | 2020-04-01 | Euroimmun Medizinische Labordiagnostika AG | Diagnosis of a neuroautoimmune disease |
| KR102252879B1 (ko) * | 2019-11-15 | 2021-05-17 | 성균관대학교산학협력단 | 혈장 내 aimp2를 이용한 파킨슨 질환의 진단 방법, 이를 위한 조성물 및 이를 포함하는 키트 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
| FR2686087A1 (fr) | 1992-01-13 | 1993-07-16 | Inst Nat Sante Rech Med | Nouvel antigene lymphocytaire, anticorps correspondant et leurs applications. |
| WO1999050300A1 (en) * | 1998-03-30 | 1999-10-07 | The Trustees Of The University Of Pennsylvania | Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders |
| JP2004502781A (ja) * | 2000-07-07 | 2004-01-29 | パナシア ファーマシューティカルズ インコーポレーテッド | 神経組織の損傷を予防するため、およびα−シヌクレイン疾患を処置するための方法 |
| GB0203446D0 (en) * | 2002-02-14 | 2002-04-03 | Univ Lancaster | Detection and/or monitoring of synuclein-related diseases |
| WO2007011907A2 (en) * | 2005-07-19 | 2007-01-25 | University Of Rochester | Alpha-synuclein antibodies and methods related thereto |
| SI2436696T1 (sl) | 2007-01-05 | 2017-10-30 | University Of Zurich | Anti-beta-amiloidno protitelo in načini njegove uporabe |
| CN101308144A (zh) * | 2007-05-16 | 2008-11-19 | 首都医科大学宣武医院 | 检测受试者体液内疾病相关蛋白聚合能力的方法 |
| PL2282758T3 (pl) * | 2008-04-29 | 2019-04-30 | Bioarctic Ab | Przeciwciała i szczepionki do zastosowania w terapeutycznych i diagnostycznych sposobach dla zaburzeń związanych z alfa-synukleiną |
| JP5810413B2 (ja) * | 2008-12-19 | 2015-11-11 | バイオジェン インターナショナル ニューロサイエンス ゲーエムベーハー | ヒト抗アルファシヌクレイン自己抗体 |
| CN101692092B (zh) * | 2009-09-24 | 2013-04-10 | 首都医科大学宣武医院 | 定量检测人血清中自体α-突触核蛋白抗体的方法 |
-
2012
- 2012-10-29 JP JP2014540007A patent/JP6263473B2/ja active Active
- 2012-10-29 US US14/355,743 patent/US20140295465A1/en not_active Abandoned
- 2012-10-29 CN CN201710252366.1A patent/CN107091931A/zh active Pending
- 2012-10-29 BR BR112014010664A patent/BR112014010664A2/pt not_active Application Discontinuation
- 2012-10-29 EP EP12846452.6A patent/EP2773957B1/en active Active
- 2012-10-29 WO PCT/US2012/062430 patent/WO2013066818A1/en active Application Filing
- 2012-10-29 CA CA2854131A patent/CA2854131C/en active Active
- 2012-10-29 AU AU2012332814A patent/AU2012332814B2/en active Active
- 2012-10-29 KR KR1020147014713A patent/KR102036938B1/ko active IP Right Grant
- 2012-10-29 CN CN201280065165.6A patent/CN104040342A/zh active Pending
- 2012-10-29 EA EA201490883A patent/EA034213B1/ru unknown
- 2012-10-29 MX MX2014005378A patent/MX356797B/es active IP Right Grant
-
2014
- 2014-04-30 IL IL232373A patent/IL232373B/en active IP Right Grant
- 2014-05-27 ZA ZA2014/03879A patent/ZA201403879B/en unknown
-
2015
- 2015-03-02 HK HK15102107.9A patent/HK1201585A1/xx unknown
-
2017
- 2017-01-19 US US15/409,671 patent/US20180011112A1/en not_active Abandoned
-
2018
- 2018-05-16 US US15/981,691 patent/US20190094245A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014533357A5 (xx) | ||
| FI2897981T3 (fi) | Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä | |
| JP2015530971A5 (xx) | ||
| JP2012512634A5 (xx) | ||
| CA2953809C (en) | Humanized anti-tau antibodies | |
| JP2013500940A5 (xx) | ||
| JP2014511179A5 (xx) | ||
| RU2017123549A (ru) | Антитела, нацеленные на антиген созревания в-клеток, и способы их применения | |
| RU2018107658A (ru) | Новые антитела против pd-l1 | |
| JP2017507652A5 (xx) | ||
| JP2018500014A5 (xx) | ||
| RU2014153675A (ru) | Антитела к с-концевым и центральным эпитопам а-бета | |
| JP2014523401A5 (xx) | ||
| JP2010187674A5 (xx) | ||
| JP2013500941A5 (xx) | ||
| JP6263473B2 (ja) | 脳における高レベルのα−シヌクレインを診断するための抗α−シヌクレイン抗体の使用 | |
| JP2020510845A5 (xx) | ||
| BR112016013338A2 (pt) | anticorpo pd-1, fragmento de ligação do antígeno do mesmo e uso médico do mesmo | |
| RU2017145653A (ru) | Средства, пути применения и способы лечения синуклеопатии | |
| JP2010526028A5 (xx) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2012518425A5 (xx) | ||
| JP2018502840A5 (xx) | ||
| JP2015523962A5 (xx) | ||
| JP2013506428A5 (xx) |